Back to search results

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer (Diagnosis) · Prostate Cancer Stage IV · CV Risk

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cedars Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Clinical Trial Recruitment Navigator) · GroupCancerTrialInformation@cshs.org · 13104232133
    Contact: Principal Investigator (Katelyn Atkins, MD, PhD)
    Contact: Principal Investigator (Leslie Ballas, MD)
Study leads

  • Katelyn Atkins, MD, PhD

    Principal Investigator

    Cedars-Sinai Medical Center

  • Leslie Ballas, MD

    Principal Investigator

    Cedars-Sinai Medical Center

View source on ClinicalTrials.gov(opens in a new tab)